皮罗尼病低强度体外冲击波疗法:一个印度的经验
Krishnendu Maiti1, Swadeep Kumar Srivastava1, Dilip Kumar Pal1
1Department of Urology, IPGME and R and SSKM Hospital, Kolkata, West Bengal, India.
概括
低强度体外冲击波疗法 (LiESWT) 在治疗印度男性皮罗尼病 (PD) 方面表现有前途. 治疗有效地减少了疼痛和斑块大小,提供了潜在的替代疗法.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 安德罗学与人类学
- 再生医学是一种再生医学.
背景情况:
- 皮罗尼氏病 (PD) 是一种连接组织疾病,影响阴茎的膜.
- 对于印度人群中PD的低强度体外冲击波疗法 (LiESWT) 的研究有限.
研究的目的:
- 评估LiESWT在被诊断患有皮罗尼病的印度患者中的疗效.
- 评估LiESWT对疼痛,斑块大小,阴茎曲和勃起功能的影响.
主要方法:
- 一项前性研究涉及25名印度PD患者,他们每周接受LiESWT会话6周.
- 评估包括国际勃起功能指数 (IIEF) -5问卷,疼痛视觉模拟量表,以及斑块大小和阴茎曲率的测量.
- 维持了6个月的随访期以评估结果.
主要成果:
- 64%的患者减轻了疼痛,20%的患者减少了≥50%的斑块大小.
- 36%的患者观察到勃起功能得到改善 (IIEF-5评分增加≥3).
- 在化斑块患者 (P=0.03) 中,发现斑块大小显著减少,而非化斑块患者的疼痛减少更大 (P=0.002).
结论:
- LiESWT是皮罗尼病的潜在替代治疗方法,显示了疼痛和斑块大小的显著改善.
- 斑块化的存在可能会影响LiESWT在PD患者的治疗结果.
- 需要进一步的研究来优化对皮罗尼病的LiESWT协议.
更多相关视频
05:17Treatment Protocol for Rotator Cuff Calcific Tendinitis Using a Single-Crystal Piezoelectric Focused Shock Wave Source
Published on: December 23, 2022
2.7K
02:21Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
692
相关概念视频
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
189
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
189
01:30Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69